Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.)

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
McCune, Michael Grant Senior Officer of Issuer Officer
Transaction date
Sale
Price
330.86
Quantity 3,486 -7.4%
Value CA$4,122,649
Storey, Annie Director of Issuer Non-Executive Director
Transaction date
Sale
Price
465.91
Quantity 82,894 +49.1%
Value CA$3,062,012
Storey, Annie Director of Issuer Non-Executive Director
Transaction date
Sale
Price
172.45
Quantity 65,045 +15.7%
Value CA$2,793,429
2.3
ThreeD Capital Inc. 10% Security Holder of Issuer Large shareholder
Transaction date
Purchase
Price
0.59
Quantity 25,000 +0.7%
Value CA$14,640
2.5
Inwentash, Sheldon 10% Security Holder of Issuer, Director of Issuer Non-Executive Director Large shareholder
Transaction date
Purchase
Price
0.59
Quantity 25,000 +0.7%
Value CA$14,640
2.5
Inwentash, Sheldon 10% Security Holder of Issuer, Director of Issuer Non-Executive Director Large shareholder
Transaction date
Purchase
Price
0.30
Quantity 500,000
Value CA$150,000
Storey, Annie Director of Issuer Non-Executive Director
Transaction date
Sale
Price
0.60
Quantity 10,000 -2.6%
Value CA$6,000
Storey, Annie Director of Issuer Non-Executive Director
Transaction date
Sale
Price
0.55
Quantity 10,000 -2.5%
Value CA$5,500
2.5
Inwentash, Sheldon 10% Security Holder of Issuer, Director of Issuer Non-Executive Director Large shareholder
Transaction date
Purchase
Price
0.60
Quantity 50,000 +1.7%
Value CA$29,750
Hang, Connie Lai Senior Officer of Issuer Officer
Transaction date
Sale
Price
0.59
Quantity 5,000 -1.7%
Value CA$2,950
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2023-02-21 2023-02-06 S Sale

Senior Officer of Issuer

Officer
3,486 -7.4%
330.86
CA$4,122,649
3,486 -7.4% 330.86 CA$4,122,649
2022-08-15 2022-08-08 S Sale

Director of Issuer

Non-Executive Director
82,894 +49.1%
465.91
CA$3,062,012
82,894 +49.1% 465.91 CA$3,062,012
2022-07-13 2022-07-07 S Sale

Director of Issuer

Non-Executive Director
65,045 +15.7%
172.45
CA$2,793,429
65,045 +15.7% 172.45 CA$2,793,429
2022-06-11 2022-06-09 B Purchase

10% Security Holder of Issuer

Large shareholder
25,000 +0.7%
0.59
CA$14,640
25,000 +0.7% 0.59 CA$14,640
2022-06-11 2022-06-09 B Purchase

10% Security Holder of Issuer, Director of Issuer

Non-Executive Director Large shareholder
25,000 +0.7%
0.59
CA$14,640
25,000 +0.7% 0.59 CA$14,640
2022-06-09 2022-06-08 B Purchase

10% Security Holder of Issuer, Director of Issuer

Non-Executive Director Large shareholder
500,000
0.30
CA$150,000
500,000 0.30 CA$150,000
2022-06-08 2022-06-06 S Sale

Director of Issuer

Non-Executive Director
10,000 -2.6%
0.60
CA$6,000
10,000 -2.6% 0.60 CA$6,000
2022-06-08 2022-06-03 S Sale

Director of Issuer

Non-Executive Director
10,000 -2.5%
0.55
CA$5,500
10,000 -2.5% 0.55 CA$5,500
2022-06-08 2022-06-03 B Purchase

10% Security Holder of Issuer, Director of Issuer

Non-Executive Director Large shareholder
50,000 +1.7%
0.60
CA$29,750
50,000 +1.7% 0.60 CA$29,750
2022-06-08 2022-06-03 S Sale

Senior Officer of Issuer

Officer
5,000 -1.7%
0.59
CA$2,950
5,000 -1.7% 0.59 CA$2,950
Explore more

More insider trading research around Nirvana Life Sciences Inc. (formerly Endocan Solutions Inc.)